CNTX Shares Outstanding History

Below is a table of the CNTX shares outstanding history going back to 10/20/2021:

Date CNTX Shares Outstanding

Also see: CNTX Market Cap History
CNTX Historical Shares Outstanding:
+24.42% CAGR
CNTX Historical Shares Outstanding: +24.42% CAGR

Mouse over chart for data details
10/20/2021 ...11/6/2023
Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with hormone-dependent cancer. Co.'s business is dependent on the development, regulatory approval and commercialization of its therapeutic product candidates, ONA-XR and CLDN6xCD3 bsAb, which are in the early stages of development. We show 8 historical shares outstanding datapoints in our coverage of CNTX's shares outstanding history.

Understanding the changing numbers of CNTX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CNTX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CNTX by allowing them to research CNTX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CNTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Context Therapeutics (CNTX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CNVY Shares Outstanding History
COCP Shares Outstanding History
CODX Shares Outstanding History
COGT Shares Outstanding History
COLL Shares Outstanding History
COM Shares Outstanding History
COO Shares Outstanding History
COOL Shares Outstanding History
COR Shares Outstanding History
CORI Shares Outstanding History
More Healthcare companies »


CNTX Shares Outstanding History | | Copyright © 2017 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.